跳至主要内容
MedPath Trial logoMedPath TrialMedPath Trial Home
临床试验/EUCTR2012-003559-13-SK
EUCTR2012-003559-13-SK进行中（未招募）不适用

Clinical non-inferiority study between Daflon 1000 mg, one oral suspension in a sachet per day and Daflon 500 mg, 2 tablets daily after eight weeks of treatment in patients suffering from symptomatic Chronic Venous Disease (CVD). International, multicenter, double-blind, randomized, parallel group study

Institut de Recherches Internationales Servier0 个研究点目标入组 952 人开始时间: 2014年4月7日最近更新:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
适应症
相关药物

试验速览

阶段
不适用
状态
进行中（未招募）
入组人数
952
研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • •Patient 20 to 75 years old (inclusive),
  • •Male or female,
  • •Outpatients,
  • •Patients suffering from primary chronic venous disease
  • •Clinical class C0s to C4s on the most affected leg, according to the CEAP classification,
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1.2 Adults (18-64 years) yes
  • •F.1.2.1 Number of subjects for this age range 852
  • •F.1.3 Elderly (>=65 years) yes
  • •F.1.3.1 Number of subjects for this age range 100

排除标准

  • •Pregnancy, breastfeeding or possibility of becoming pregnant during the study

研究者

相似试验

进行中（未招募）
不适用
Clinical non-inferiority study between Daflon 1000 mg, one oral suspension in a sachet per day and Daflon 500 mg, 2 tablets daily after eight weeks of treatment in patients suffering from symptomatic Chronic Venous Disease (CVD).Patients suffering from symptomatic Chronic Venous Disease (CVD).MedDRA version: 14.1Level: LLTClassification code 10066682Term: Chronic venous insufficiencySystem Organ Class: 100000004866
EUCTR2012-003559-13-ESInstitut de Recherches Internationales Servier952
进行中（未招募）
不适用
Clinical non-inferiority study between Daflon 1000 mg, one oral suspension in a sachet per day and Daflon 500 mg, 2 tablets daily after eight weeks of treatment in patients suffering from symptomatic Chronic Venous Disease (CVD).
EUCTR2012-003559-13-CZInstitut de Recherches Internationales Servier952
进行中（未招募）
不适用
Clinical non-inferiority study between Daflon 1000 mg, one oral suspension in a sachet per day and Daflon 500 mg, 2 tablets daily after eight weeks of treatment in patients suffering from symptomatic Chronic Venous Disease (CVD).
EUCTR2012-003559-13-SIInstitut de Recherches Internationales Servier952
进行中（未招募）
不适用
Clinical non-inferiority study between Daflon 1000 mg, one oral suspension in a sachet per day and Daflon 500 mg, 2 tablets daily after eight weeks of treatment in patients suffering from symptomatic Chronic Venous Disease (CVD).
EUCTR2012-003559-13-PTInstitut de Recherches Internationales Servier952
招募中
不适用
Comparisons of different filling materials in Non carious cervical Lesion .
CTRI/2021/08/035494Dr Tanu300